Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients With Lung Cancer

Brandi R. Newsome

Karen K. McDonnell

Jennifer Hucks

Robin Dawson Estrada

chronic obstructive pulmonary disease, immunotherapy, lung cancer, quality of life
CJON 2018, 22(2), 184-192. DOI: 10.1188/18.CJON.184-192

Background: Chronic obstructive pulmonary disease (COPD) is the most common smoking-related illness. COPD often is underemphasized as a comorbidity except when considering issues surrounding surgical treatment options.

Objectives: This article aims to provide nurses with an overview of the pharmacologic and nonpharmacologic treatment implications of COPD.

Methods: Definitions, differentials, and treatment considerations are provided, and clinical implications and resources are described.

Findings: The added burden of dyspnea, fatigue, and psychological distress related to COPD may affect the overall outcome and quality of life (QOL) of patients with lung cancer. Attention to the prevention, assessment, and treatment of lung cancer and COPD and related symptomatology will help maximize patients’ QOL.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.